search
Back to results

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS (SPINNERS)

Primary Purpose

Stroke

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Non-contrast cranial MDCT head scan
Non-contrast syngo DynaCT Sine Spin head scan and application software
Sponsored by
University Hospital, Basel, Switzerland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Stroke focused on measuring hemorrhagic stroke, ischemic stroke, large-vessel occlusions (LVO), cone beam CT, intracranial hemorrhage, flat detector computer tomography (FDCT)

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Informed Consent as documented by signature or fulfilling the criteria for emergency or deferral consent
  • Patients with symptoms suggestive of ischemic stroke (NIHSS ≥ 7) or suggestive of haemorrhagic stroke with a cranial non-contrast MDCT and a feasible non-contrast syngo DynaCT Sine Spin within 4 hours
  • Patient presenting within 24 hours of last seen well
  • Patients presenting directly to the treating hospital (i.e. mothership patients) OR transfer patients with the indication for repeated imaging according to the standard operation procedures of the treating hospital
  • Age above 18 years
  • Agreement of treating physician to perform non-contrast syngo DynaCT Sine Spin

Exclusion Criteria:

  • Severe metal artifacts on initial MDCT imaging
  • Planned invasive interventions between MDCT and FDCT scan
  • Clinical deterioration between MDCT and FDCT scan (i.e. an increase of the NIHSS of more than 4 points)
  • Evidence of an ongoing pregnancy prior to enrollment. A negative pregnancy test before enrollment is required for all women with child-bearing potential

Sites / Locations

  • University Hospital BaselRecruiting
  • Inselspital BernRecruiting
  • Kantonsspital LuzernRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Cranial non-contrast syngo DynaCT Sine Spin scan

Arm Description

There is only one arm as all patients undergo the same intervention. Subjects with clinical features/symptoms of a stroke (hemorrhagic and non-hemorrhagic stroke patients) will be enrolled. All patients will undergo first a non-contrast MDCT scan and then a non-contrast syngo DynaCT Sine Spin head scan within a maximum timespan of 4 hours between both scans. Only patients in which no invasive procedure in between is planned can be enrolled.

Outcomes

Primary Outcome Measures

Occurrence of an intracranial hemorrhage (yes/no)
The primary outcome is the occurrence of intracranial hemorrhages (yes vs no) as assessed by a blinded core-lab. The primary outcome will be used to calculate the sensitivity and specificity of non-contrast syngo DynaCT Sine Spin imaging for the detection of intracranial hemorrhages. The primary outcome will be assessed on both scans.

Secondary Outcome Measures

Full Information

First Posted
June 20, 2022
Last Updated
June 13, 2023
Sponsor
University Hospital, Basel, Switzerland
Collaborators
Siemens Healthineers AG
search

1. Study Identification

Unique Protocol Identification Number
NCT05458908
Brief Title
ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS
Acronym
SPINNERS
Official Title
ProSPective Evaluation of the dIagnostic Accuracy of siNe spiN Noncontrast Flat-dEtectoR CT (FDCT) for the Detection of Intracranial Hemorrhage in Stroke Patients
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 25, 2022 (Actual)
Primary Completion Date
May 1, 2024 (Anticipated)
Study Completion Date
July 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Basel, Switzerland
Collaborators
Siemens Healthineers AG

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Stroke is one of the leading causes of mortality and disability worldwide. Optimization of intra-hospital pathways is as of today one of the most promising research topics in stroke treatment. A potential solution to shorten the time needed for current workflows, and therefore reperfusion, is to do both imaging and subsequent endovascular therapy (EVT) in the angiography suite using non-contrast syngo DynaCT Sine Spin (FDCT) for the exclusion of intracranial hemorrhage and flat detector CT angiography (FDCTA) or digital subtraction angiography for diagnosis of LVO. It is still a matter of debate if FDCT can reliably differentiate between ischemic and hemorrhagic stroke. This study aims to investigate if non-contrast syngo DynaCT Sine Spin imaging is non-inferior to non-contrast MDCT imaging regarding its sensitivity and specificity for the detection of intracranial hemorrhages.
Detailed Description
Despite concerted efforts, stroke is still one of the leading causes of mortality and disability worldwide.Stroke can be divided into two main types: ischemic and hemorrhagic stroke. Endovascular therapy (EVT) became the gold-standard for the treatment of acute ischemic stroke due to large-vessel occlusions (LVO). However, as was shown by a post-hoc meta-analysis of five trials clinical outcome is highly associated with the time from hospital admission to treatment. One possibility to substantially shorten this time span is the implementation of a One Stop Management approach. In this workflow both imaging and subsequent EVT is done in the angiography suite using non-contrast flat detector CT (FDCT) for the exclusion of an intracranial hemorrhage. Such workflows dramatically reduce intra-hospital time delays (median reductions of more than 30 minutes) and are associated with improved patient outcomes. One of the biggest hurdles for a large-scale implementation of a One Stop Management approach up to now is the ability to differentiate between ischemic and hemorrhagic stroke with FDCT. In a recent study we have reported very high sensitivity and specificity for the detection of intracranial hemorrhage with FDCT. Recently Siemens Healthineers introduced the new ARTIS icono angiography system with a new non-contrast syngo DynaCT Sine Spin protocol FDCT, which should improve the quality and soft tissue resolution of native cranial FDCT scans especially in the posterior fossa and skull base. Therefore, the study aims to evaluate if non-contrast syngo DynaCT Sine Spin FDCT is non-inferior to non-contrast multidetector CT (MDCT) for the detection of intracranial hemorrhages.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
hemorrhagic stroke, ischemic stroke, large-vessel occlusions (LVO), cone beam CT, intracranial hemorrhage, flat detector computer tomography (FDCT)

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Cross-sectional non-inferiority investigation with prospective open label data collection and blinded endpoint assessment
Masking
None (Open Label)
Masking Description
Blinded assessment of outcome events through an independent Core-Lab
Allocation
N/A
Enrollment
252 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cranial non-contrast syngo DynaCT Sine Spin scan
Arm Type
Experimental
Arm Description
There is only one arm as all patients undergo the same intervention. Subjects with clinical features/symptoms of a stroke (hemorrhagic and non-hemorrhagic stroke patients) will be enrolled. All patients will undergo first a non-contrast MDCT scan and then a non-contrast syngo DynaCT Sine Spin head scan within a maximum timespan of 4 hours between both scans. Only patients in which no invasive procedure in between is planned can be enrolled.
Intervention Type
Diagnostic Test
Intervention Name(s)
Non-contrast cranial MDCT head scan
Intervention Description
Non-contrast cranial MDCT imaging for visualization of the brain parenchyma (the choice of the device is up to the investigator)
Intervention Type
Diagnostic Test
Intervention Name(s)
Non-contrast syngo DynaCT Sine Spin head scan and application software
Intervention Description
Non-contrast syngo DynaCT Sine Spin imaging for visualization of the brain parenchyma with ARTIS icono biplane angiography system and syngo application software with syngo DynaCT Sine Spin 3-D head imaging protocol.
Primary Outcome Measure Information:
Title
Occurrence of an intracranial hemorrhage (yes/no)
Description
The primary outcome is the occurrence of intracranial hemorrhages (yes vs no) as assessed by a blinded core-lab. The primary outcome will be used to calculate the sensitivity and specificity of non-contrast syngo DynaCT Sine Spin imaging for the detection of intracranial hemorrhages. The primary outcome will be assessed on both scans.
Time Frame
Day 0 - within 4 hours of enrollment
Other Pre-specified Outcome Measures:
Title
Change in Adverse Device Events (ADEs)
Description
All device related adverse events (ADEs) will be evaluated up to 24 hours after the study intervention.
Time Frame
At 24 h ± 6h after enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Informed Consent as documented by signature or fulfilling the criteria for emergency or deferral consent Patients with symptoms suggestive of ischemic stroke (NIHSS ≥ 7) or suggestive of haemorrhagic stroke with a cranial non-contrast MDCT and a feasible non-contrast syngo DynaCT Sine Spin within 4 hours Patient presenting within 24 hours of last seen well Patients presenting directly to the treating hospital (i.e. mothership patients) OR transfer patients with the indication for repeated imaging according to the standard operation procedures of the treating hospital Age above 18 years Agreement of treating physician to perform non-contrast syngo DynaCT Sine Spin Exclusion Criteria: Severe metal artifacts on initial MDCT imaging Planned invasive interventions between MDCT and FDCT scan Clinical deterioration between MDCT and FDCT scan (i.e. an increase of the NIHSS of more than 4 points) Evidence of an ongoing pregnancy prior to enrollment. A negative pregnancy test before enrollment is required for all women with child-bearing potential
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marios-Nikos Psychogios, Prof Dr
Phone
+41 61 328 59 36
Email
marios.psychogios@usb.ch
First Name & Middle Initial & Last Name or Official Title & Degree
Alex Brehm, PhD
Phone
+41 61 328 51 72
Email
alex.brehm@usb.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marios-Nikos Psychogios, Prof Dr
Organizational Affiliation
University Hospital, Basel, Switzerland
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Adam S Arthur, MD, MPH
Organizational Affiliation
Semmes Murphey Clinic and University of Tennessee Health Sciences Center
Official's Role
Study Chair
Facility Information:
Facility Name
University Hospital Basel
City
Basel
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alex Brehm, PhD
First Name & Middle Initial & Last Name & Degree
Marios-Nikos Psychogios, Prof Dr
Facility Name
Inselspital Bern
City
Bern
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Johannes Kaesmacher, PD Dr
Email
johannes.kaesmacher@insel.ch
First Name & Middle Initial & Last Name & Degree
Johannes Kaesmacher, PD Dr
Facility Name
Kantonsspital Luzern
City
Luzern
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Grzegorz Karwacki, Dr
Email
grzegorz.karwacki@luks.ch
First Name & Middle Initial & Last Name & Degree
Grzegorz Karwacki, Dr
First Name & Middle Initial & Last Name & Degree
Alexander von Hessling, Dr

12. IPD Sharing Statement

Citations:
PubMed Identifier
35318960
Citation
Petroulia VD, Kaesmacher J, Piechowiak EI, Dobrocky T, Pilgram-Pastor SM, Gralla J, Wagner F, Mordasini P. Evaluation of Sine Spin flat detector CT imaging compared with multidetector CT. J Neurointerv Surg. 2023 Mar;15(3):292-297. doi: 10.1136/neurintsurg-2021-018312. Epub 2022 Mar 22.
Results Reference
background
PubMed Identifier
29018132
Citation
Psychogios MN, Behme D, Schregel K, Tsogkas I, Maier IL, Leyhe JR, Zapf A, Tran J, Bahr M, Liman J, Knauth M. One-Stop Management of Acute Stroke Patients: Minimizing Door-to-Reperfusion Times. Stroke. 2017 Nov;48(11):3152-3155. doi: 10.1161/STROKEAHA.117.018077. Epub 2017 Oct 10.
Results Reference
background
PubMed Identifier
27998955
Citation
Leyhe JR, Tsogkas I, Hesse AC, Behme D, Schregel K, Papageorgiou I, Liman J, Knauth M, Psychogios MN. Latest generation of flat detector CT as a peri-interventional diagnostic tool: a comparative study with multidetector CT. J Neurointerv Surg. 2017 Dec;9(12):1253-1257. doi: 10.1136/neurintsurg-2016-012866. Epub 2016 Dec 20.
Results Reference
background

Learn more about this trial

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

We'll reach out to this number within 24 hrs